Elisabeth de Vries
Rijksuniversiteit Groningen
H-index: 139
Europe-Netherlands
Top articles of Elisabeth de Vries
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial) | NPJ Breast Cancer | Magdalena Mileva Elisabeth GE de Vries Thomas Guiot Zéna Wimana Anne-Leen Deleu | 2024/1/6 |
Abstract PO2-13-03: Spatial HER2 heterogeneity on HER2-PET in HER2-low and negative disease: potential biomarker for antibody-drug conjugate effect | Cancer Research | Carolien Schroder Jasper van Geel Bertha Eisses Adrienne Brouwers Sjoerd Elias | 2024/5/2 |
Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop … | JCO Precision Oncology | Erica C Nakajima Amber Simpson Jan Bogaerts Elisabeth GE de Vries Richard Do | 2024/4 |
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma | Nature Medicine | Johannes R Björk Laura A Bolte Andrew Maltez Thomas Karla A Lee Niccolo Rossi | 2024/2/16 |
Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic … | Diagnostics | Jorianne Boers Bertha Eisses Mieke C Zwager Jasper JL van Geel Frederike Bensch | 2024/2/14 |
[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant | Clinical Cancer Research | Ramsha Iqbal Maqsood Yaqub Huseyyin O Bektas Daniela E Oprea-Lager Elisabeth GE de Vries | 2023/6/1 |
LAG-3 PET imaging in patients with cancer before immune checkpoint inhibitor therapy | Cancer Research | Pim P van de Donk Lotte M Smit Joyce van Sluis Wim Timens Adrienne H Brouwers | 2023/4/4 |
Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors | ESMO open | SF Oosting AAM van der Veldt RSN Fehrmann A Bhattacharya RS van Binnendijk | 2023/8/1 |
Opportunities on the horizon for the management of early colon cancer | Daan G Knapen Jacco J de Haan Rudolf SN Fehrmann Elisabeth GE de Vries Derk Jan A de Groot | 2023/3/1 | |
Meta-Analysis of the Test–Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response | Clinical Cancer Research | Lalitha K Shankar Erich Huang Saskia Litiere Otto S Hoekstra Larry Schwartz | 2023/1/4 |
Towards evidence-based response criteria for cancer immunotherapy | Scott Laurie Lesley Seymour Elisabeth de Vries Elena GARRALDA | 2023/5/24 | |
Optimisation of scan duration and image quality in oncological 89Zr immunoPET imaging using the Biograph Vision PET/CT | European Journal of Nuclear Medicine and Molecular Imaging | Joyce van Sluis Ronald Boellaard Rudi AJO Dierckx Evelien LM van Esch Demi A Croes | 2023/7 |
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) credit | Annals of Oncology | SF Oosting Jorge Barriuso A Bottomley M Galotti B Gyawali | 2023/4/1 |
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma | Bmc cancer | Alessia Visconti Niccolò Rossi Helena Deriš Karla A Lee Maja Hanić | 2023/2/18 |
Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma | Josef Rüschoff Martijn Lolkema LUCA GIANNI Emile Voest Elisabeth de Vries | 2023 | |
2286P COVID-19 vaccinations in cancer patients (pts): An individual participant data meta-analysis of the International Consortium on COVID vaccination in cancer | Annals of Oncology | HML Le AM Schmitt STC Shepherd A Bhattacharya C Bresee | 2023/10/1 |
Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer | Rudolf Fehrmann Daan Knapen Sara Hone Lopez Derk Jan de Groot Jacco de Haan | 2023/5/8 | |
Manual Versus Artificial Intelligence-Based Segmentations as a Pre-processing Step in Whole-body PET Dosimetry Calculations | Molecular Imaging and Biology | Joyce van Sluis Walter Noordzij Elisabeth GE de Vries Iris C Kok Derk Jan A de Groot | 2023/4 |
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI … | Madeline Pe Ahu Alanya Ragnhild Sorum Falk Cecilie Delphin Amdal Kristin Bjordal | 2023/6/1 | |
One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment | ESMO open | AAM van der Veldt SF Oosting RSN Fehrmann CH GeurtsvanKessel RS van Binnendijk | 2023/2/1 |
Co-Authors
